More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Mouse anti CD65s, conjugated to FITC

Mouse anti CD65s, conjugated to FITC

Research Use Only
GM-4102-CE/IVD
Nordic-MUbio
ApplicationsFlow Cytometry, ImmunoFluorescence
Product group Antibodies
ReactivityHuman
Price on request
2.0 ml
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Nordic-MUbio
  • Product Name
    Mouse anti CD65s, conjugated to FITC
  • Delivery Days Customer
    7
  • Applications
    Flow Cytometry, ImmunoFluorescence
  • Applications Supplier
    Direct Immunofluorescence;Immunofluoresence;Flow Cytometry;Immunofluoresence
  • Category Supplier
    Primary antibodies
  • Certification
    Research Use Only
  • Clone ID
    VIM2
  • Conjugate
    FITC
  • Host
    Mouse
  • Isotype
    IgM
  • Source
    VIM2 was produced after immunization of mice with an extract of THP-1, a monocytic cell line derived from a patient with acute monocytic leukemia.
  • Reactivity
    Human
  • Reactivity Supplier
    Human
  • Storage Instruction
    Nordic-MUbio monoclonal antibody reagents contain optimal concentrations of affinity-purified antibody. For stability reasons this monoclonal antibody solution contains sodium azide. These reagents should be stored at 2-8°C (DO NOT FREEZE!) and protected from prolonged exposure to light. If a slight precipitation occurs upon storage, this should be removed by centrifugation. It will not affect the performance or the concentration of the product. Stability of the reagent: Please refer to the ...
  • UNSPSC
    12352203

References

  • 1. O. Majdic et al., Int J Cancer 33, 617 (1984). 2. P. Bettelheim et al., Leuk Res 9, 1323 (1985). 3. C. Peschel et al., Exp Hematol 13, 1211 (1985). 4. K. Uemura et al., Biochim Biophys Acta 846, 26 (1985). 5. D. Lutz et al., Onkologie 9, 67 (1986). 6. R. Delwel, F. Bot, W. Knapp, B. Lowenberg, Bone Marrow Transplant 2, 149 (1987). 7. B. A. Macher, J. Buehler, P. Scudder, W. Knapp, T. Feizi, J Biol Chem 263, 10186 (1988). 8. U. Koller et al., Leukemia 3, 708 (1989) 9. B. A. Macher, J. H. Beckstead, Leuk Res 14, 119 (1990). 10. I. Schwarzinger et al., J Clin Oncol 8, 423 (1990). 11. J. B. Lowe et al., J Biol Chem 266, 17467 (1991). 12. T. A. Springer, L. A. Lasky, Nature 349, 196 (1991). 13. F. Lund-Johansen et al., J Immunol 148, 3221 (1992). 14. F. M. Fink et al., Med Pediatr Oncol 21, 340 (1993). 15. F. Lund-Johansen et al., Eur J Immunol 23, 2782 (1993). 16. J. Stockl et al., J Leukoc Biol 53, 541 (1993). 17. W. Knapp, H. Strobl, O. Majdic, Cytometry 18, 187 (1994). 18. G. M. Brown, T. N. Huckerby, B. L. Abram, I. A. Nieduszynski, Biochem J 319 ( Pt 1), 137 (1996). 19. J. L. Clarke, W. Watkins, J Biol Chem 271, 10317 (1996). 20. R. N. Knibbs et al., J Cell Biol 133, 911 (1996). 21. B. Kniep et al., J Biochem (Tokyo) 119, 456 (1996). 22. A. J. Wagers, L. M. Stoolman, R. Kannagi, R. Craig, G. S. Kansas, J Immunol 159, 1917 (1997). 23. M. Noguchi, N. Sato, H. Sugimori, K. Mori, K. Oshimi, Leuk Res 25, 847 (2001). 24. W. M. Watkins, J. L. Clarke, Adv Exp Med Biol 491, 231 (2001).